IQVIA™ Real-World Insights Bibliography

The Effect of Medicare's Annual Wellness Visit on Preventive Care for the Elderly
Author(s): Miao Jiang; Danny Hughes; Wenyi Wang
Affiliations(s): Miao Jiang (IQVIA); Danny Hughes (Georgia Tech and Neiman HPI); Wenyi Wang (Medstar)
Publication(s):  Preventive Medicine
Document Type(s): Article,
Countries: USA,
C:
Y:
Health economics, Health policy,
2018
  L:
A:
English
Observational study, Population Based Study, Public Health, Retrospective cohort analysis,
  Add to report
 
 
Use of Breast Cancer Screening and Its Association with Later Use of Preventive Services among Medicare Beneficiaries
Author(s): Stella Kang; Miao Jiang; Richard Duszak, Jr.; Samantha Heller; Danny Hughes; Linda Moy
Affiliations(s): Stella Kang (Department of Radiology, NYU School of Medicine); Miao Jiang (IQVIA);
Publication(s):  Radiology
Document Type(s): Article,
Countries: USA,
Click here for the abstract
C:
Y:
Health policy, Oncology,
2018
  L:
A:
English
Observational study, Population Based Study, Public Health, Retrospective cohort analysis,
  Add to report
 
 
The impact of the new innovative algorithm in Italy
Author(s): Rova A1, Cioni L1, Urbinati D1
Affiliations(s): 1 IQVIA, RWI, Milan, Italy
Publication(s):  ISPOR 21st Annual European Congress, 10-14 November 2018, Barcelona, Spain
Document Type(s): Poster,
Countries: Italy,
C:
Y:
Health policy, Public Health, Regulatory,
2018
  L:
A:
English
  Add to report
 
 
The evolution of standard monitoring registries in the Italian market
Author(s): Cioni L1, Rova A1, Urbinati D1
Affiliations(s): 1 IQVIA, RWI, Milan, Italy
Publication(s):  ISPOR 21st Annual European Congress, 10-14 November 2018, Barcelona, Spain
Document Type(s): Poster,
Countries: Italy,
C:
Y:
Health policy, Public Health, Regulatory,
2018
  L:
A:
English
  Add to report
 
 
Comparative Analysis of the Market Penetration of Personalised Medicine Drugs Under the Conditions of AMNOG
Author(s): Fischer T, Bonduelle D, Antoni B
Affiliations(s): IQVIA Commercial GmbH & Co. OHG, Munich, Germany
Publication(s): 
Document Type(s): Abstract,
Countries: Germany,
C:
Y:
Health economics, Health policy,
2018
  L:
A:
German
Market impact,
  Add to report
 
 
Guidelines in Germany Early Benefit Assessment - Which Guidelines are Considerend by Federal Joint Committee for Determing the Appropriate Comparator?
Author(s): Scheler E, Stratil AS, Roxlau T, Bonduelle D
Affiliations(s): IQVIA Commercial GmbH & Co. OHG, Munich, Germany
Publication(s): 
Document Type(s): Abstract,
Countries: Germany,
C:
Y:
Guidelines, Health policy,
2018
  L:
A:
German
Review,
  Add to report
 
 
Success Factors for §137h SGB V Assessment of Medical Devices in Germany
Author(s): Bonduelle, Doreen; von Hein, Mirko; Scheler, Elisabeth
Affiliations(s): IQVIA Commercial GmbH & Co. OHG, Munich, Germany
Publication(s): 
Document Type(s): Abstract,
Countries: Germany,
C:
Y:
Health policy,
2018
  L:
A:
English
Review,
  Add to report
 
 
Overview of German AMNOG Dossiers with Price Analysis Before and After Early Benefit Assessment
Author(s): Tremmel M, Batscheider A, Bocuk D, Roxlau T, Antoni B, Elena Mihaylova, Bonduelle D
Affiliations(s): IQVIA Commercial GmbH & Co. OHG, Munich, Germany IQVIA RDS Bulgaria EOOD, Sofia, Bulgaria
Publication(s): 
Document Type(s): Abstract,
Countries: 
C:
Y:
Health economics, Health policy, Pricing and reimbursement,
2018
  L:
A:
English
Pricing & Reimbursement, Review,
  Add to report
 
 
The Impact of Label Extensions on the Reimbursed Price of Pharmaceutical Products Assessed According to §35A SGB V in Germany Oncological and Metabolic Diseases
Author(s): Schmalhofer C, Eheberg D, Tremmel M, Bocuk D, Roxlau T, Antoni B, Bonduelle D
Affiliations(s): IQVIA Commercial GmbH & Co. OHG, Munich, Germany
Publication(s): 
Document Type(s): Abstract,
Countries: Germany,
C:
Y:
Health economics, Health policy, Metabolic Disorders , Oncology, Pricing and reimbursement,
2018
  L:
A:
English
Cost analysis, Pricing & Reimbursement,
  Add to report
 
 
Off-Label Prescription of Drugs Compared to Prescription After Label Extension in Children for Germany
Author(s): Gohlke A, Kostev K, Kuschel AS
Affiliations(s): IQVIA Commercial GmbH & Co. OHG, Munich, Germany
Publication(s): 
Document Type(s): 
Countries: 
C:
Y:
Health policy, Pediatrics, Regulatory,
2018
  L:
A:
English
Utility analysis,
  Add to report
 
 
 1 of 11 Next Page Last Page